Skip to main content
SpringerLink
Log in

Current Approaches to the Clinical Diagnosis of Alzheimer’s Disease

  • Chapter
Book cover Early Diagnosis of Alzheimer’s Disease

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Assessing the value of new diagnostic approaches to Alzheimer’s disease (AD) requires an appreciation of the “standard” clinical diagnostic evaluation. In reality, there is no single, universally accepted clinical approach to the evaluation of demented patients. The workup is likely to vary from setting to setting. Different approaches may be found, for example, among primary care physicians, clinical neurologists in the community, and dementia researchers in academic centers. With the growth of managed care programs, more explicit standards may be established, perhaps with an increased emphasis on containing costs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer’s disease (CERAD). Neurology 1995:45:461–466.

    Article  PubMed  CAS  Google Scholar 

  2. Katzman R. Alzheimer’s disease. N Engl J. Med. 1986;314:964–973.

    Article  PubMed  CAS  Google Scholar 

  3. Kokmen E, Beard CM, Offord KP, Kurland LT. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota. Neurology 1989;39:773–776.

    Article  PubMed  CAS  Google Scholar 

  4. Smith JS, Kilch LG. The investigation of dementia: results in 200 consecutive admissions. Lancet 1981;2:824–827.

    Article  Google Scholar 

  5. Rocca WA, Amaducci LA, Schoenberg BS. Epidemiology of clinically diagnosed Alzheimer’s disease. Ann. Neurol 1986;19:415–424.

    Article  PubMed  CAS  Google Scholar 

  6. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer’s disease in a retirement community. Am. J. Epidemiol. 1987;125:420–436.

    PubMed  CAS  Google Scholar 

  7. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ. Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551–2556.

    Article  PubMed  CAS  Google Scholar 

  8. Schumock GT. Economic considerations in the treatment and management of Alzheimer’s disease. Am. J. Health Syst. Pharm. 1998;55(Suppl. 2):S17-S21.

    PubMed  Google Scholar 

  9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.

    Google Scholar 

  10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, et al Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984;34:939–944.

    Article  PubMed  CAS  Google Scholar 

  11. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al The consortium to establish a registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;3:1159–1165.

    Google Scholar 

  12. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486.

    Article  PubMed  CAS  Google Scholar 

  13. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer’s disease. Neurology 1993;43:2457–2465.

    Article  PubMed  CAS  Google Scholar 

  14. American Academy of Neurology. Practice parameter for the diagnosis and evaluation of dementia (summary statement). Neurology 1994;44:2203–2206.

    Article  Google Scholar 

  15. Corey-Bloom J, Thai LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. Diagnosis and evaluation of dementia. Neurology 1995;45:211–218.

    Article  PubMed  CAS  Google Scholar 

  16. Council on Scientific Affairs, American Medical Association. Dementia. JAMA 1986;256:2234–2238.

    Article  Google Scholar 

  17. Consensus Conference. Differential diagnosis of dementing diseases. JAMA 1987;258:3411–3416.

    Article  Google Scholar 

  18. McGlone J, Gupta S, Humphrey D, Oppenheimer S, Mirsen T, Evans DR. Screening for early dementia using memory complaints from patients and relatives. Arch. Neurol. 1990;47:1189–1193.

    Article  PubMed  CAS  Google Scholar 

  19. Flicker C, Ferris SH, Reisberg B. A longitudinal study of cognitive function in elderly persons with subjective memory complaints. J. Am. Geriatr. Soc. 1993;41: 1029–1032.

    PubMed  CAS  Google Scholar 

  20. Folstein MF, Folstein SE, McHaugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12:189–198.

    Article  PubMed  CAS  Google Scholar 

  21. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the gray matter of elderly subjects. Br. J. Psychiatry 1968;114:797–811.

    Article  PubMed  CAS  Google Scholar 

  22. Magaziner J, Bassett SS, Hebel JR. Predicting performance on the Mini-Mental State Examination: use of age- and education-specific equations. J.Am. Geriatr. Soc. 1987;35:996–1000.

    PubMed  CAS  Google Scholar 

  23. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA 1993;269:2386–91.

    Article  PubMed  CAS  Google Scholar 

  24. Huff FJ, Growdon JH, Corkin S, Rosen TJ. Age at onset and rate of progression of Alzheimer’s disease. J. Am. Geriatr. Soc. 1987;35:27–30.

    PubMed  CAS  Google Scholar 

  25. Huff FJ, Growdon JH, Corkin S, Rosen TJ. Deterioration of Blessed information-memory-concentration test in Alzheimer’s disease. Psychiatry Res. 1992;4:167–168.

    Article  Google Scholar 

  26. Katzman R, Brown T, Thai LJ, Fuld PA, Aronson M, Butters N, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s disease. Ann. Neurol. 1988;24:384–389.

    Article  PubMed  CAS  Google Scholar 

  27. Salmon DP, Thai LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology 1990;40:1225–1230.

    Article  PubMed  CAS  Google Scholar 

  28. Nelson A, Fogel BS, Faust D. Bedside cognitive screening instruments: a critical assessment. J. Nerv. Ment. Dis. 1986;174:73–83.

    Article  PubMed  CAS  Google Scholar 

  29. Panisset M, Roudier M, Saxton J, Boller F. Severe impairment battery: a neuropsychological test for severely demented patients. Arch. Neurol. 1994;51:41–45.

    Article  PubMed  CAS  Google Scholar 

  30. Weintraub S, Mesulam MM. Four neuropsychological profiles in dementia. In Boiler F, Grafman J, editors. Handbook of Neuropsychology, Volume 8. Amsterdam: Elsevier Science Publishers BV, 1993:253–282.

    Google Scholar 

  31. Daffner KR. Alzheimer’s disease and related disorders. In Samuels MA, Feske S, editors. Office Practice of Neurology. New York: Churchill Livingstone, 1996: 710–715.

    Google Scholar 

  32. Chui HC. Dementia: a review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch. Neurol. 1989;46:806–814.

    Article  PubMed  CAS  Google Scholar 

  33. Mayeux R, Stern Y, Spanto S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453–461.

    Article  PubMed  CAS  Google Scholar 

  34. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, et al. The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 1990;40:1–8.

    Article  PubMed  CAS  Google Scholar 

  35. Marsden CD, Harrison MJG. Outcome of investigation of patients with presenile dementia. BMJ 1972;2:249–252.

    Article  PubMed  CAS  Google Scholar 

  36. Clarfield AM. The reversible dementias: do they reverse? Ann. Intern. Med. 1988;109:476–486.

    PubMed  CAS  Google Scholar 

  37. Larson EB, Reitler BV, Sumi SM, Canfield CG, Chann NM. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch. Intern. Med. 1986;146:1917–1922.

    Article  PubMed  CAS  Google Scholar 

  38. Weytingh MD, Bossuyt PMM, van Crevel H. Reversible dementia: more than 10% or less than 1%: a quantitative review. J. Neurol. 1995;242:466–471.

    Article  PubMed  CAS  Google Scholar 

  39. Brodaty H. Consensus statement on predictive testing for Alzheimer disease and associated disorders. Alzheimer Dis. Assoc. Disord. 1995;9:182–187.

    PubMed  CAS  Google Scholar 

  40. Bird T. Apolipoprotein E genotyping in the diagnosis of Alzheimer’s disease: a cautionary view. Ann. Neurol. 1995;38:2–3.

    Article  PubMed  CAS  Google Scholar 

  41. Relkin NR, Kwon YJ, Tsai J, Grandy S. The National Institute on Aging/ Alzhemer’s Association recommendations on the application of apolipoprotein e genotyping to Alzheimer’s disease. Ann NY Acad Sei 1996;802:149–173.

    Article  CAS  Google Scholar 

  42. Post SG, Whitehouse PJ, Binstock RH, et al The clinical introduction of genetic testing for Alzheimer’s disease: an ethical perspective. JAMA 1997;277:832–836.

    Article  PubMed  CAS  Google Scholar 

  43. Farrer L, Brin M, Elsas L, Goate A, Kennedy J, Mayeux R, et al. Statement on the use of apolipoprotein E testing for Alzheimer disease (AD). JAMA 1995;274: 1627–1629.

    Article  Google Scholar 

  44. Johnson KA, Davis KR, Buonanno FS, Brady TJ, Rosen J, Growdon JH. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Arch. Neurol. 1987;44:1075–1080.

    Article  PubMed  CAS  Google Scholar 

  45. Hunt AL, Orrison WW, Yeo RA, Haaland KY, Rhyne RL, Garry PJ, et al. Clinical significance of MRI white matter lesions in the elderly. Neurology 1989;39: 1470–1474.

    Article  PubMed  CAS  Google Scholar 

  46. Benson DF. Neuroimaging and dementia. Neurol. Clin. 1986;4:341–353.

    PubMed  CAS  Google Scholar 

  47. Clarfield AM, Larson EB. Should a major imaging procedure (CT or MRI) be required in the workup of dementia?: an opposing view. J. Fam. Pract. 1990;31: 405–410.

    PubMed  CAS  Google Scholar 

  48. Bradshaw JR, Thomson JLG, Campbell M J. Computed tomography in the investigation of dementia. BMJ 1983;286:277–280.

    Article  PubMed  CAS  Google Scholar 

  49. Katzman R. Should a major imaging procedure (CT or MRI) be required in the workup of dementia?: an affirmative view. J. Fam. Pract. 1990;31:401–410.

    PubMed  CAS  Google Scholar 

  50. The Lund and Manchester Groups. Consensus Statement: clinical and neu-ropathological criteria for frontotemporal dementia. J. Neurol, Neurosurg. Psychiatry 1994;57:416–418.

    Article  Google Scholar 

  51. Starkstein SE, Migliorelli R, Teson A, Sabe L, Vazquez S, Turjanski M, et al. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J. Neurol. Neurosurg. Psychiatry 1994;57:790–796.

    Article  PubMed  CAS  Google Scholar 

  52. Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, et al. Frontal lobe degeneration: clinical, neuropsychological and SPECT characteristics. Neurology 1991;41:1374–1382.

    Article  PubMed  CAS  Google Scholar 

  53. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661–665.

    Article  PubMed  CAS  Google Scholar 

  54. Masur DM, Shwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427–1432.

    Article  PubMed  CAS  Google Scholar 

  55. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer’s disease. Neurology 1995;45:957–962.

    Article  PubMed  CAS  Google Scholar 

  56. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, et al. The “preclinical phase” of probable Alzheimer’s disease. Arch. Neurol. 1995;52: 485–490.

    Article  PubMed  CAS  Google Scholar 

  57. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 1992;42:631–639.

    Article  PubMed  CAS  Google Scholar 

  58. Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer’s disease. Arch. Neurol. 1995;52:1087–1099.

    Article  PubMed  CAS  Google Scholar 

  59. Paque L, Warrington EK. A longitudinal study of reading ability in patients suffering from dementia. /. Int. Neuropsychol. Soc. 1995;1:517–524.

    Article  CAS  Google Scholar 

  60. Grober E, Śliwiński M, Korey SR. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J. Clin. Exp. Neuropsychol. 1991;13:933–949.

    Article  PubMed  CAS  Google Scholar 

  61. Ivnik RJ, Malec JF, Smith GE. Mayo’s older Americans normative studies, WAIS-R, WMS-R, and AVLT norms for ages 56 through 97. Clin. Neuropsychol. 1992;6:1–104.

    Google Scholar 

  62. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests’ norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin. Neuropsychol. 1996;10:262–278.

    Article  Google Scholar 

  63. Becker PM, Feussner JR, Mulrow CD, Williams BC, Vokaty KA. The role of lumbar puncture in the evaluation of dementia: the Durham Veterans Administration/Duke University study. J. Am. Geriatr. Soc. 1985;33:392–396.

    PubMed  CAS  Google Scholar 

  64. Hammerstrom DC, Zimmer B. The role of lumbar puncture in the evaluation of dementia: the University of Pittsburgh study. J. Am. Geriatr. Soc. 1985;33: 397–400.

    PubMed  CAS  Google Scholar 

  65. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14–3–3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl. J. Med. 1996;335:924–930.

    Article  PubMed  CAS  Google Scholar 

  66. Rosemann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R. Detection of 14–3–3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 1997;49:593–595.

    Article  Google Scholar 

  67. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14–3–3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol. 1998;43:32–40.

    Article  PubMed  CAS  Google Scholar 

  68. Weber T, Otto M, Bodemer M, Zerr I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed. Pharmacother. 1997;51: 381–387.

    Article  PubMed  CAS  Google Scholar 

  69. Duffy FH, Albert MS, McAnulty G. Brain electric activity in patients with senile and presenile dementia of the Alzheimer type. Ann. Neurol. 1984;16:439–448.

    Article  PubMed  CAS  Google Scholar 

  70. Leuchter AF, Spar JE, Walter DO, Weiner H. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer’s-type and multi-infarct dementia. Arch. Gen. Psychiatry 1987;44:993–998.

    Article  PubMed  CAS  Google Scholar 

  71. American Academy of Neurology. Therapeutics and technology assessment subcommittee: assessment: EEG brain mapping. Neurology 1989;39:1100–1101.

    Article  Google Scholar 

  72. Brown P, Cathala F, Sadowsky D, Gajdusek DC. Creutzfeldt-Jakob disease in France II: clinical characteristics of 124 consecutive cases during the decade, 1968–1977. Ann. Neurol. 1979;6:430–437.

    Article  PubMed  CAS  Google Scholar 

  73. Katzman R, Lasker B, Bernstein N. Advances in the diagnosis of dementia: accuracy of diagnosis and consequences of misdiagnosis of disorders causing dementia. In Terry RD, editor. Aging and the Brain. New York: Raven Press, 1988:17–62.

    Google Scholar 

  74. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Yates PO, et al. Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. J. Neurol. Neurosurg. Psychiatry 1986;49:157–162.

    Article  PubMed  CAS  Google Scholar 

  75. Hulette CM, Earl NL, Crain BJ. Evaluation of cerebral biopsies for the diagnosis of dementia. Arch. Neurol 1992;49:28–31.

    Article  PubMed  CAS  Google Scholar 

  76. Flicker C, Ferris SH, Crook T, Bartuś RT, Reisberg B. Cognitive function in normal aging and early dementia. In Traber J, Gispen WH, editors. Senile Dementia of the Alzheimer Type. NY: Springer-Verlag, 1985:2–17.

    Chapter  Google Scholar 

  77. Craik FIM. Age differences in human memory. In Birren JE, Schaie KW, editors. Handbook of the Psychology of Aging. New York: Van Nostrand Reinhold, 1977:384–420.

    Google Scholar 

  78. Craik FIM. Memory functions in normal aging. In Yanagihara T, Petersen RC, editors. Memory Disorders: Research and Clinical Practice. New York: Marcel Dekker, 1992:347–367.

    Google Scholar 

  79. Ardilia A, Rosselli M. Neuropsychological characteristics of normal aging. Dev. Neuropsychol. 1989;5:307–320.

    Article  Google Scholar 

  80. Petersen RC, Smith G, Kokmen E, Ivnik RJ, Tangalos EG. Memory function in normal aging. Neurology 1992;42:396–401.

    Article  PubMed  CAS  Google Scholar 

  81. Francis J, Martin D, Kapor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990;263:1097–1101.

    Article  PubMed  CAS  Google Scholar 

  82. Schor JD, Levkoff SE, Lipsitz LA, Reilly CH, Cleary PD, Rowe JW, et al. Risk factors for delirium in hospitalized elderly. JAMA 1992;267:827–831.

    Article  PubMed  CAS  Google Scholar 

  83. Adams RD. Delirium and other acute confusional states. In Adams RD, Victor M, Ropper AH, editors., Principles of Neurology, 6th ed. New York: McGraw-Hill, 1997:405–416.

    Google Scholar 

  84. Bozzola FG, Gorelick PB, Freels S. Personality changes in Alzheimer’s disease. Arch. Neurol. 1992;49:297–300.

    Article  PubMed  CAS  Google Scholar 

  85. Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ. Assessment of behavioral and affective symptoms in Alzheimer’s disease. J. Geriatr. Psychiatry Neurol. 1990;3:21–30.

    Article  PubMed  CAS  Google Scholar 

  86. Clark A, White III CL, Manz HJ, Parhad IM, Curry B, Whitehouse PJ, et al. Primary degenerative dementia without Alzheimer pathology. Can. J. Neurol. Sei. 1986;13:462–470.

    CAS  Google Scholar 

  87. Eggerston DE, Sima AAR Dementia with cerebral Lewy bodies: a mesocortical dopaminergic deficit? Arch. Neurol. 1986;43:524–527.

    Article  Google Scholar 

  88. Knopman DS, Mastric AR, Frey II WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990;40:251–256.

    Article  PubMed  CAS  Google Scholar 

  89. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch. Gerontol. Geriatr. 1987;6:209–223.

    Article  PubMed  CAS  Google Scholar 

  90. Neary D, Snowden JS, Northen B, Goulding P. Dementia of frontal lobe type. J. Neurol. Neurosurg. Psychiatry 1988;51:353–361.

    Article  PubMed  CAS  Google Scholar 

  91. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch. Gerontol. Geriatr. 1987;6:193–208.

    Article  PubMed  CAS  Google Scholar 

  92. Albert ML, Feldman RG, Willis AL. The “subcortical dementia” of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 1974;37:121–130.

    Article  PubMed  CAS  Google Scholar 

  93. Cummings JL, Benson DF. Subcortical dementia: review of an emerging concept. Arch. Neurol. 1984;41:874–879.

    Article  PubMed  CAS  Google Scholar 

  94. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986;9:357–381.

    Article  PubMed  CAS  Google Scholar 

  95. Cummings JL. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993;50:873–880.

    Article  PubMed  CAS  Google Scholar 

  96. Mendez MF, Cherrier M, Perryman KM, Pachana N, Miller BL, Cummings JL. Frontotemporal dementia versus Alzheimer’s disease: differential cognitive features. Neurology 1996;47:1189–1194.

    Article  PubMed  CAS  Google Scholar 

  97. Stevens M, van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, Scheltens P, Ravid R, Oostra BA, Niermeijer MF, van Swieten JC. Familial aggregation in frontotemporal dementia. Neurology 1998;50:1541–1545.

    Article  PubMed  CAS  Google Scholar 

  98. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 1999;64:414–421.

    Article  PubMed  CAS  Google Scholar 

  99. Foster NL, Wilhelmsen, K, Sima AAF, Jones MZ, D’Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consenus conference. Conference Participants. Ann. Neurol. 1997;41:706–715.

    Article  PubMed  CAS  Google Scholar 

  100. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferner IN, Thompson P, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994; 44:872–877.

    Article  PubMed  CAS  Google Scholar 

  101. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinically and neuropathologically distinct type of Lewy body dementia in the elderly. /. Neurol. Sei. 1990;95:119–139.

    Article  CAS  Google Scholar 

  102. McKeith IG, Galasko D, Kosaka K, Perry EK, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.

    Article  PubMed  CAS  Google Scholar 

  103. Reding M, Haycox J, Wigforss K, Brush D, Blass JP. Follow-up of patients referred to a dementia service. J. Am. Geriatr. Soc. 1984;32:265–268.

    PubMed  CAS  Google Scholar 

  104. McCallister TW, Price TRP. (1982) Severe depressive pseudodementia with and without dementia. Am. J. Psychiatry 1982; 139:5.

    Google Scholar 

  105. Kral VA. The relationship between senile dementia (Alzheimer type) and depression. Can. J. Psychiatry 1983;28:304–306.

    PubMed  CAS  Google Scholar 

  106. Patterson C. The diagnosis and differential diagnosis of dementia and pseudo-dementia in the elderly. Can. Fam. Physician 1986;32:2607–2610.

    PubMed  CAS  Google Scholar 

  107. Lopez OL, Boller F, Becker JT, Miller M, Reynolds III CF. Alzheimer’s disease and depression: neuropsychological impairment and progression of disease. Am. J. Psychiatry 1990;147:855–860.

    PubMed  CAS  Google Scholar 

  108. Rovner BW, Broadhead J, Spencer M, Carson K, Folstein M. Depression and Alzheimer’s disease. Am. J. Psychiatry 1989;146:350–353.

    PubMed  CAS  Google Scholar 

  109. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and postmortem neuropathol-gical study. /. Neurol. Neurosurg. Psychiatry 1988;51:1037–1044.

    Article  CAS  Google Scholar 

  110. Molsa PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinico-pathological study. J. Neurol. Neurosurg. Psychiatry 1985;48:1085–1090.

    Article  PubMed  CAS  Google Scholar 

  111. Brust JCM. Vascular dementia is overdiagnosed. Arch. Neurol. 1988;45:799–801.

    Article  PubMed  CAS  Google Scholar 

  112. Wade JPH, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer’s disease. Arch. Neurol. 1987;44:24–29.

    Article  PubMed  CAS  Google Scholar 

  113. O’Brien MD. Vascular dementia is underdiagnosed. Arch. Neurol. 1988;45: 797–798.

    Article  PubMed  Google Scholar 

  114. Tomlinson BE, Blessed S, Roth M. Observations on the brains of demented old people. Neurol. Sei. 1970;11:205–242.

    Article  CAS  Google Scholar 

  115. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer’s disease. JAMA 1997;277:813–817

    Article  PubMed  CAS  Google Scholar 

  116. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 1986;19:517–524.

    Article  PubMed  CAS  Google Scholar 

  117. Perry S W. Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am. J. Psychiatry 1990;147:696–710.

    PubMed  CAS  Google Scholar 

  118. Merritt HH, Adams RD, Solomon H. Neurosyphilis. Oxford: New York.

    Google Scholar 

  119. Adams RD, Victor M, Ropper AH. Infections of the nervous system (bacterial, fungal, spirochetal, parasitic) and sarcoid. In Principles of Neurology, 6th ed. New York: McGraw-Hill, 1997:695–741.

    Google Scholar 

  120. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure: a treatable syndrome. N Engl. J. Med. 1965;273:117–126.

    Article  PubMed  CAS  Google Scholar 

  121. Fisher CM. The clinical picture in occult hydrocephalus. Clin. Neurosurg. 1977; 24:240–284.

    Google Scholar 

  122. Caltagirone C, Gainotti G, Masullo C, Villa G. Neuropsychological study of normal pressure hydrocephalus. Acta Psychiatr. Scand. 1982;65:93–100.

    Article  PubMed  CAS  Google Scholar 

  123. Stambrook M, Gill DD, Cardoso E, Moore AD. Communicating (normal-pressure) hydrocephalus. In Parks RW, Zee RF, Wilson RS, editors. Neuropsychology of Alzheimer’s Disease and Other Dementias. New York: Oxford University Press, 1993:283–307.

    Google Scholar 

  124. Thomsen AM, Brogesen SE, Bruhn P, Gjerris F. Prognosis of dementia in normal-pressure hydrocephalus after a shunt operation. Ann. Neurol. 1986; 20:304–310.

    Article  PubMed  CAS  Google Scholar 

  125. Bradley WG, Whittmore AR, Kortman KE, Watanabe AS, Homyak M, Teresi LM, et al. Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. Radiology 1991;178:459–466.

    PubMed  Google Scholar 

  126. Wikkelso C, Andersson H, Blomstrand C, Lindqvist G, Svendsen P. Normal pressure hydrocephalus: predictive value of the cerebrospinal fluid tap-test. Acta Neurol. Scand. 1986;73:566–573.

    Article  PubMed  CAS  Google Scholar 

  127. Vanneste J, Augustijn P, Davies GAG, Dirven C, Tan WF. Normal pressure hydrocephalus: is cisternography still useful in selecting patients for a shunt? Arch. Neurol. 1992;49:366–370.

    Article  PubMed  CAS  Google Scholar 

  128. Mindin SL, Schiffer RB. Affective disorders in multiple sclerosis. Arch. Neurol. 1990;47:98–104.

    Article  Google Scholar 

  129. van den Burg W, van Zomeren AH, Minderhound JM, Prange AJA, Meijer NSA. Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch. Neurol. 1987;44:494–501.

    Article  PubMed  Google Scholar 

  130. Rabins PV, Brooks BR, O’Donnell P, Pearlson GD, Moberg P, Jubelt B, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986;109:585–597.

    Article  PubMed  Google Scholar 

  131. Huber S J, Cumming JL, Parkinson’s Disease, Neurobehavioral Aspects. New York: Oxford University Press, 1992.

    Google Scholar 

  132. Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, et al. An estimate of the prevalence of dementia in idiopathic Parkinson’s disease. Arch. Neurol 1988;45:260–262.

    Article  PubMed  CAS  Google Scholar 

  133. Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer’s and Parkinson’s disease. Arch. Neurol. 1993;50: 1040–1045.

    Article  PubMed  CAS  Google Scholar 

  134. Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, et al. Dementia in Parkinson’s disease. Ann. Neurol. 1979;6:355–359.

    Article  PubMed  CAS  Google Scholar 

  135. Shoulson I. Huntington’s disease: cognitive and psychiatric features. Neuropsychiatry Neuropsychol. Behav. Neurol. 1990;3:15–22.

    Google Scholar 

  136. Folstein SE, Folstein MF. Psychiatric features of Huntington’s disease: recent approaches and findings. Psychiatr. Dev. 1983;2:193–205.

    Google Scholar 

  137. Butters N, Wolfe J, Granholm E, Martone M. An assessment of verbal recall, recognition and fluency abilities in patients with Huntington’s disease. Cortex 1986;22:11–32.

    PubMed  CAS  Google Scholar 

  138. Brouwers P, Cox C, Martin A, Chase T. Differential perceptual-spatial impairment in Huntington’s and Alzheimer’s dementias. Arch. Neurol. 1984;41:1073–1076.

    Article  PubMed  CAS  Google Scholar 

  139. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch. Neurol. 1990;47:553–558.

    Article  PubMed  CAS  Google Scholar 

  140. Goffinet AM, De Voider AG, Gillain C, Rectem D, Bol A, Michel C, et al. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann. Neurol. 1989;25:131–139.

    Article  PubMed  CAS  Google Scholar 

  141. Dening TR, Berrios GE. Wilson’s disease: psychiatric symptoms in 195 cases. Arch. Gen. Psychiatry 1989;46:1126–1134.

    Article  PubMed  CAS  Google Scholar 

  142. Rosselli M, Lorenzana P, Rosselli A, Vergara I. Wilson’s disease, a reversible dementia: case report. J. Clin. Exp. Neuropsychol. 1987;9:399–406.

    Article  PubMed  CAS  Google Scholar 

  143. Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Inter-relation between “classic” motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J. Neurol. Neurosurg. Psychiatry 1995;58:541–547.

    Article  PubMed  CAS  Google Scholar 

  144. Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, Macdermott N. Frontal lobe dementia and motor neuron disease. J. Neurol. Neurosurg. Psychiatry 1990;53:23–32.

    Article  PubMed  CAS  Google Scholar 

  145. Mesulam MM, Weintraub S. Spectrum of primary progressive aphasia. In Rossor MN, editor. Unusual Dementia, Bailliere’s Clinical Neurology, Vol 1. 1992: 583–609.

    Google Scholar 

  146. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann. Neurol. 1982;11:592–598.

    Article  PubMed  CAS  Google Scholar 

  147. Mesulam MM. Primary progressive aphasia: differentiation from Alzheimer’s disease. Ann. Neurol 1987;2:533–534.

    Article  Google Scholar 

  148. Heath PD, Kennedy P, Kapur N. Slowly progressive aphasia without generalized dementia. Ann. Neurol. 1983;13:687–688.

    Article  PubMed  CAS  Google Scholar 

  149. Grossman M, Mickanin J, Onishi K, et al. Progressive non-fluent aphasia: language, cognitive, and PET measures contrasted with probable Alzheimer’s disease. J. Cognitive Neurosci. 1996;8:135–154.

    Article  Google Scholar 

  150. Green J, Morris JC, Sandson J, McKeel DW, Miller JW. Progressive aphasia: a precursor of global dementia? Neurology 1990;40:423–429.

    Article  PubMed  CAS  Google Scholar 

  151. Karbe H, Kertesz A, Polk M. Profile of language impairment in primary progressive aphasia. Arch. Neurol. 1993;50:193–201.

    Article  PubMed  CAS  Google Scholar 

  152. Cogan DG. Visual disturbances with focal progressive dementing disease. Am. J. Ophthal. 1985;100:68–72.

    PubMed  CAS  Google Scholar 

  153. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45:789–793.

    Article  PubMed  CAS  Google Scholar 

  154. Tyrell PJ, Warrington EK, Frąckowiak RS J, Rossor MN. Progressive degeneration of the right temporal lobe studied with positron emission tomography. J. Neurol Neurosurg. Psychiatry 1990;53:1046–1050.

    Article  Google Scholar 

  155. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV Posterior cortical atrophy: neuropathological correlations. Arch. Neurol. 1994;51:269–274.

    Article  PubMed  CAS  Google Scholar 

  156. De Renzi E. Slowly progressive visual agnosia or apraxia without dementia. Cortex 1986;22:171–180.

    PubMed  Google Scholar 

  157. Dick JPR, Snowden J, Northen B. et al. Slowly progressive apraxia. Behav. Neurol. 1989;2:101–114.

    Google Scholar 

  158. Evans JJ, Heggs AJ, Antoun N, Hodges JR. Progressive prosopagnosia associated with selective right temporal lobe atrophy: a new syndrome? Brain 1995; 118:1–13.

    Article  PubMed  Google Scholar 

  159. Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behav. Neurol 1989;2:167–182.

    Google Scholar 

  160. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby M, Hughes J. The validity of 3 clinical diagnostic criteria for Alzheimer’s disease. Neurology 1990;40:1364–1369.

    Article  PubMed  CAS  Google Scholar 

  161. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, et al. The NINCDS-ADRDA Workgroup criteria for the clinical diagnosis of probable of Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988;38: 359–364.

    Article  PubMed  CAS  Google Scholar 

  162. Morris JC, McKeel DW, Fulling K, Torack RM, Berę L. Validation of clinical diagnostic criteria for Alzheimer’s disease. Ann. Neurol. 1988;24:17–22.

    Article  PubMed  CAS  Google Scholar 

  163. Price BH, Gurvit H, Weintraub S. Neuropsychological patterns and language deficits in twenty consecutive cases of autopsy-confirmed Alzheimer’s disease. Arch. Neurol. 1993;50:931–937.

    Article  PubMed  CAS  Google Scholar 

  164. Risse SC, Raskind MA, Nochlin D, Sumi SM, Lampe TH, Bird TD, et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer’s disease. Am. J. Psychiatry 1990;147:168–172.

    PubMed  CAS  Google Scholar 

  165. Mendez M, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer’s disease: neuropathologic findings in 650 cases. Alzheimer Dis. Assoc. Disord. 1992; 6:35–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Kirk R. Daffner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Leonard F. M. Scinto PhD  & Kirk R. Daffner MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this chapter

Cite this chapter

Daffner, K.R. (2000). Current Approaches to the Clinical Diagnosis of Alzheimer’s Disease. In: Scinto, L.F.M., Daffner, K.R. (eds) Early Diagnosis of Alzheimer’s Disease. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-005-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-005-6_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9601-7

  • Online ISBN: 978-1-59259-005-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation